A mature life sciences business chain
Excellent research alone does not yet create a business. It needs to be recognised and transferred. Valorisation typically occurs through industrial partnerships with large national and international R&D competent companies, through small and medium enterprises or through the creation of new start-ups. Translational research can be an important valorisation route for health related research.
The Amsterdam BioMed Cluster consists of two internationally renowned universities with their academic medical centres, a number of independent scientific research institutes and successful and specialist biomedical and life science companies, making the Amsterdam region a global competitor in the commercialisation of their specific areas of life sciences. Numerous life sciences support organisations, such as investors, supply companies, and service companies, are part of the network.
The biomedical sector is a strategic one for Amsterdam. Hence, facilities and space at excellent locations are made available for biomedical and life science companies or institutes considering a base in the region.
Amsterdam offers superb opportunities:
- Access to large numbers of patients and patient material
- Fast approval processes for clinical trials
- Fast patent procedure
- Extensive knowledge infrastructure
- Top-class technical and Internet facilities
